[Central visual syndromes].
D000890:Anti-Infective Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D000978:Antiparkinson Agents / Q000009:adverse effects; D001766:Blindness / Q000139:chemically induced; D002317:Cardiovascular Agents / Q000009:adverse effects; D003118:Color Perception / Q000187:drug effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D008881:Migraine Disorders / Q000139:chemically induced; D010276:Parasympatholytics / Q000009:adverse effects; D010468:Perceptual Disorders / Q000139:chemically induced*; D011619:Psychotropic Drugs / Q000009:adverse effects; D014793:Visual Cortex / Q000187:drug effects; D014796:Visual Perception / Q000187:drug effects*
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D000978:Antiparkinson Agents; D002317:Cardiovascular Agents; D003276:Contraceptives, Oral; D010276:Parasympatholytics; D011619:Psychotropic Drugs
Les syndromes visuels centraux.